Experience of human lymphotropic virus type I (HTLV-I) in an East London hospital. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Experience of human lymphotropic virus type I (HTLV-I) in an East London hospital.

J Infect. 1996 Jan;32(1):33-9. Unique Identifier : AIDSLINE MED/97005238
Hoque S; Kelsey S; van der Walt JD; Breuer J; Department of Medical Microbiology, Royal London Hospital, U.K.

Abstract: We describe the experience of The Royal London Hospital with human T-cell lymphotropic virus type 1 (HTLV-1) related disease. Twelve patients presented from 1988-1993, nine of them in 1993. None were born in the U.K. and 11 were of West Indian origin. Ten had overt lymphomas, one tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM) and one atypical lymphocytosis and Strongyloidiasis. Five presented acutely ill to Casualty and three died shortly after presentation. Four had been referred to rheumatologists and five had predominantly gastrointestinal symptoms. The population of Caribbean origin served by the hospital is 23,700 and one would only expect one or two cases of lymphoma and one or two cases of TSP/HAM per year. Overall the spectrum of clinical disease at presentation was varied. Suspicion of HTLV-1 infection is merited in patients of West Indian origin between the ages of 30-65 years, who present with a sarcoid-like illness, gastrointestinal symptoms, leukaemia/lymphoma, myelopathy or myositis like-illness.
Keywords: Adult Case Report Fatal Outcome Female Hospitals, Municipal Human *HTLV-I HTLV-I Infections/ETHNOLOGY Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/*ETHNOLOGY London Male Middle Age West Indies/ETHNOLOGY JOURNAL ARTICLEKWDadultcasereportfataloutcomefemalehospitals,municipalhumanKWDhtlv-ihtlv-iinfections/ethnologyleukemia-lymphoma,t-cell,acute,htlv-i-associated/KWDethnologylondonmalemiddleagewestindies/ethnologyjournalarticle
970228
M9721850

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .